Page last updated: 2024-08-17

medroxyprogesterone acetate and Weight Gain

medroxyprogesterone acetate has been researched along with Weight Gain in 77 studies

Research

Studies (77)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.60)	18.7374
1990's	17 (22.08)	18.2507
2000's	30 (38.96)	29.6817
2010's	27 (35.06)	24.3611
2020's	1 (1.30)	2.80

Authors

Authors	Studies
Bekele, T; Ferede, YM; Malik, T; Yeshaw, Y; Zerihun, MF	1
Kassahun-Yimer, W; Lutz, E; Ngwudike, C; Shwayder, J; Sims, J; Wallace, K	1
Antell, K; Brown, EJ; Deshmukh, P	1
Bahamondes, L; Fernandes, A; Peipert, JF; Qadir, S; Silva, P	1
Allsworth, JE; Madden, T; Peipert, JF; Secura, GM; Vickery, Z; Zhao, Q	1
Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Trussell, J	1
Bonny, AE; Gothard, DM; Lange, HL; Reed, MD; Rogers, LK	1
Bahamondes, L; Bahamondes, MV; Bottura, BF; Dal'Ava, N; Monteiro, I	1
Raleigh, M; Yancey, JR	1
Bahamondes, L; Bahamondes, MV; Dal'Ava, N; Fernandes, A; Modesto, W; Silva dos Santos, P	1
Bahamondes, MV; Dal'Ava, N; dos Santos, Pde N; Fernandes, A; Modesto, WO; Pavin, EJ	1
Bahamondes, L; Borges, L; Correia, VM; de Nazaré Silva dos Santos, P; Modesto, W	1
Belury, MA; Bonny, AE; Lange, HL; Secic, M; Thomas, A	1
Bonny, AE; Hade, EM; Kaufman, B; Lange, HL; Mesiano, S; Reed, MD	1
Bahamondes, L; Cursino, K; dos Santos, Pde N; Fernandes, A; Pavin, EJ; Sider, M; Zantut-Wittmann, DE	1
Albright, M; Gavagan, T; Rani, S	1
Dragoman, MV; Gaffield, ME	1
Anderson, L; Bao, P; Basu, T; Lerner, A; Mishell, D; Page, K; Segall-Gutierrez, P; Stanczyk, F	1
Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Ramesh, S; Trussell, J	1
Berenson, AB; Breitkopf, CR; Odom, SD; Rahman, M	1
Emans, SJ; Pitts, SA	1
Berenson, AB; Rahman, M	1
Berenson, AB; Le, YL; Rahman, M	1
Beksinska, ME; Farley, TM; Kleinschmidt, I; Milford, C; Smit, JA	1
Baccarin, MC; Bahamondes, L; Fernandes, AM; Medeiros, T; Morais, SS; Pantoja, M	1
Bonny, AE; Cromer, BA; Secic, M	1
Gerlach, LS; Nick, TG; Saldaña, SN; Spigarelli, MG; Wang, Y	1
Bonny, AE; Cromer, B; Secic, M	1
Chen-Mok, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Trussell, J	1
Edelman, A; Kaneshiro, B	1
Madden, T; Nault, AM; Peipert, JF; Secura, GM; Zhao, Q	1
Habash, DL; Nyirati, CM; Shaffer, LE	1
Pelkman, C	1
Akhter, M; Khan, MR; Mia, AR; Shampa, SS; Siddiqui, NI	1
Lech, MM	1
Bonny, AE; Britto, MT; Huang, B; Slap, GB; Succop, P	1
Thommasen, HV	1
Levine, JP	1
Huang, B; Huppert, JS; Slap, GB; Tuchman, LK	1
Bonny, AE; Cromer, BA; Harkness, LS	1
Shittu, O; Sule, S	1
Jain, JK; Milsom, I; Ray, A; Westhoff, C	1
Darney, PD; Haider, S	1
Dedeoğlu, EN; Erenus, M; Yörük, P	1
Granfors, E; Heikkinen, J; Hirvonen, E; Hulkko, S; Mäkäräinen, L; Nummi, S; Pekonen, F; Puolakka, J; Rautio, AM; Salmi, T	1
Fink, W; McDougall, C; Moore, LL; Valuck, R	1
Westhoff, C	1
Cushman, LF; Davidson, AR; Heartwell, S; Kalmuss, D; Rulin, M	1
Sangruchi, S	1
Henderson, KA; Matson, SC; McGrath, GJ	1
Atley, L; Ebeling, PR; Eyre, DR; Lentle, BC; Li, DK; Prior, JC; Vigna, YM; Wark, JD	1
Paul, C; Skegg, DC; Williams, S	1
Barnabei, VM; Barrett-Connor, E; Greendale, GA; Hogan, P; Johnson, S; Reboussin, BA; Shumaker, S	1
Bahamondes, L; Diaz, J; Hall, P; Petta, C	1
Boroditsky, RS	1
Cromer, BA	1
el-Hussinie, M; el-Nahal, N; Hassan, EO	1
Cromie, MA; Garceau, RJ; Kaunitz, AM	1
Kissner, DG	1
Gupta, M	1
Boyd, H; Hertweck, SP; Templeman, C	1
Cromer, BA; Stager, MM	1
Acs, N; Miklós, Z; Monos, E; Nádasy, GL; Székács, B; Tökés, AM; Vajó, Z; Várbíró, S	1
Kaunitz, AM	2
Espey, E; Ogburn, T; Qualls, C; Steinhart, J	1
Stefanick, ML	1
Al-Bar, HM; Archibong, EI; Sadek, AA; Sobande, AA	1
Arce, XE; Bahamondes, L; Del Castillo, S; Perrotti, M; Petta, C; Tabares, G	1
Besch-Williford, C; Day, JK; Hufford, MG; Lubahn, DB; MacDonald, RS; McMann, TR	1
Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S	1
Hudson, S; Larsen, PG; Mangan, SA	1
Biro, F; Flanagan, P; Harel, Z; Kollar, L; Riggs, S; Vaz, R	1
Cooper, L; Hart, BL	1
Dupuis, M; Gimotty, P; Russo, IH; Russo, J	1
Inaii, H; Koyama, H; Noguchi, S; Yamamoto, H	1

Reviews

21 review(s) available for medroxyprogesterone acetate and Weight Gain

Article	Year
Contraception Update: Progestin-Only Implants and Injections. FP essentials, 2017, Volume: 462 Topics: Contraceptive Agents, Female; Device Removal; Drug Implants; Drug Interactions; Family Planning Services; Family Practice; Female; Humans; Injections; Medroxyprogesterone Acetate; Progestins; Weight Gain	2017
Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2018, Volume: 51, Issue:6 Topics: Body Mass Index; Clinical Trials as Topic; Contraceptive Agents, Female; Energy Intake; Feeding Behavior; Female; Humans; Medroxyprogesterone Acetate; Weight Gain	2018
Progestin-only contraceptives: effects on weight. The Cochrane database of systematic reviews, 2013, Jul-02, Issue:7 Topics: Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain	2013
Progestin-only contraceptives: effects on weight. American family physician, 2014, May-01, Volume: 89, Issue:9 Topics: Adolescent; Adult; Contraceptive Agents, Female; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Progestins; Weight Gain	2014
The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review. Contraception, 2016, Volume: 94, Issue:3 Topics: Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Endometriosis; Female; HIV Infections; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone Acetate; Obesity; Pain; Patient Satisfaction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Weight Gain; World Health Organization	2016
Progestin-only contraceptives: effects on weight. The Cochrane database of systematic reviews, 2016, Aug-28, Issue:8 Topics: Adolescent; Adult; Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Prospective Studies; Retrospective Studies; Weight Gain	2016
Controversies in contraception. Current opinion in pediatrics, 2008, Volume: 20, Issue:4 Topics: Adolescent; Contraception; Contraceptive Agents, Female; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Migraine Disorders; Obesity; Osteoporosis; Venous Thromboembolism; Weight Gain	2008
Retrospective review of the relationship between weight change and demographic factors following initial depot medroxyprogesterone acetate injection in adolescents. Clinical therapeutics, 2011, Volume: 33, Issue:2 Topics: Adolescent; Child; Contraceptive Agents; Delayed-Action Preparations; Humans; Injections, Intramuscular; Linear Models; Medroxyprogesterone Acetate; Menarche; Obesity; Retrospective Studies; Weight Gain	2011
Progestin-only contraceptives: effects on weight. The Cochrane database of systematic reviews, 2011, Apr-13, Issue:4 Topics: Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain	2011
Contraceptive considerations in overweight teens. Current opinion in obstetrics & gynecology, 2011, Volume: 23, Issue:5 Topics: Adolescent; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Medroxyprogesterone Acetate; Overweight; Pregnancy; Pregnancy in Adolescence; United States; Weight Gain	2011
Hormones and weight change. The Journal of reproductive medicine, 2002, Volume: 47, Issue:9 Suppl Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Double-Blind Method; Energy Intake; Energy Metabolism; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; United States; Weight Gain	2002
[Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2003, Volume: 56, Issue:7-8 Topics: Adult; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Family Planning Services; Female; Humans; Injections; Medroxyprogesterone Acetate; Poland; Pregnancy; Weight Gain; Women's Health	2003
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences. The Journal of family practice, 2004, Volume: 53, Issue:11 Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health	2004
Depot medroxyprogesterone acetate: implications for weight status and bone mineral density in the adolescent female. Adolescent medicine clinics, 2005, Volume: 16, Issue:3 Topics: Adolescent; Body Composition; Bone Density; Clinical Trials as Topic; Contraceptive Agents, Female; Cross-Cultural Comparison; Female; Humans; Medroxyprogesterone Acetate; Obesity; Patient Dropouts; Pregnancy; Pregnancy in Adolescence; Risk Factors; Weight Gain	2005
Injectable contraception. Clinical obstetrics and gynecology, 2007, Volume: 50, Issue:4 Topics: Abdominal Pain; Anxiety; Contraceptive Agents, Female; Dizziness; Estradiol; Female; Headache; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Safety; Weight Gain	2007
Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes. The Journal of reproductive medicine, 1996, Volume: 41, Issue:5 Suppl Topics: Affect; Bone and Bones; Carbohydrate Metabolism; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Lipids; Medroxyprogesterone Acetate; Metabolism; Weight Gain	1996
Depo-Provera: an ideal contraceptive for adolescents? Journal of pediatric and adolescent gynecology, 1999, Volume: 12, Issue:2 Topics: Adolescent; Adolescent Behavior; Contraceptive Agents, Female; Depression; Fatigue; Female; Health Knowledge, Attitudes, Practice; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Compliance; Patient Selection; Psychology, Adolescent; Weight Gain	1999
Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera). Current opinion in obstetrics & gynecology, 1999, Volume: 11, Issue:5 Topics: Bone Density; Contraceptive Agents, Female; Female; Galactorrhea; Humans; Medroxyprogesterone Acetate; Patient Satisfaction; Weight Gain	1999
Injectable contraception. New and existing options. Obstetrics and gynecology clinics of North America, 2000, Volume: 27, Issue:4 Topics: Affect; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Estradiol; Female; History, 20th Century; Humans; Injections; Medroxyprogesterone Acetate; Pregnancy; Risk Factors; Weight Gain	2000
Injectable long-acting contraceptives. Clinical obstetrics and gynecology, 2001, Volume: 44, Issue:1 Topics: Affect; Bone Density; Chemistry, Pharmaceutical; Contraceptive Agents, Female; Contraindications; Delayed-Action Preparations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Education as Topic; Patient Selection; Pharmacoepidemiology; Risk Factors; United States; United States Food and Drug Administration; Weight Gain	2001
Estrogen, progestogens and cardiovascular risk. The Journal of reproductive medicine, 1999, Volume: 44, Issue:2 Suppl Topics: Aged; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Drug Administration Schedule; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone; Progesterone Congeners; Progestins; Weight Gain	1999

Trials

15 trial(s) available for medroxyprogesterone acetate and Weight Gain

Article	Year
A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females. Contraception, 2014, Volume: 89, Issue:5 Topics: Adolescent; Child; Contraceptive Agents, Female; Female; Healthy Volunteers; Humans; Medroxyprogesterone Acetate; Pilot Projects; Prospective Studies; Weight Gain; Young Adult	2014
Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2014, Volume: 19, Issue:4 Topics: Adolescent; Adult; Body Composition; Bone Density; Calcium, Dietary; Contraceptive Agents, Female; Counseling; Female; Humans; Life Style; Medroxyprogesterone Acetate; Motor Activity; Osteoporosis; Sunlight; Weight Gain; Young Adult	2014
Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:3 Topics: Adipose Tissue; Adolescent; Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Weight Gain; Young Adult	2009
Effect of prolonged use of injectable hormonal contraceptives on blood pressure and body weight. Mymensingh medical journal : MMJ, 2004, Volume: 13, Issue:1 Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Female; Humans; Injections; Medroxyprogesterone Acetate; Weight Gain	2004
Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women. Fertility and sterility, 2009, Volume: 91, Issue:2 Topics: Adiposity; Adult; Body Mass Index; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Leptin; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Time Factors; Treatment Outcome; Waist-Hip Ratio; Weight Gain	2009
Can progestin be limited to every third month only in postmenopausal women taking estrogen? Maturitas, 1995, Volume: 21, Issue:1 Topics: Adult; Aged; Climacteric; Drug Administration Schedule; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Postmenopause; Prospective Studies; Treatment Outcome; Weight Gain	1995
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA, 1995, Jan-18, Volume: 273, Issue:3 Topics: Aged; Cholesterol, HDL; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Glucose; Heart Diseases; Humans; Insulin; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Systole; Weight Gain	1995
The myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiation. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1996, Volume: 79, Issue:9 Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Double-Blind Method; Female; Hematocrit; Humans; Leukocyte Count; Medroxyprogesterone Acetate; Prospective Studies; Uterine Cervical Neoplasms; Weight Gain	1996
Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:11 Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium, Dietary; Double-Blind Method; Estrogen Replacement Therapy; Female; Femur; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis; Ovariectomy; Premenopause; Progesterone Congeners; Thoracic Vertebrae; Weight Gain	1997
Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstetrics and gynecology, 1998, Volume: 92, Issue:6 Topics: Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Feeding and Eating Disorders; Female; Headache; Humans; Medroxyprogesterone Acetate; Memory; Middle Aged; Mood Disorders; Neurobehavioral Manifestations; Vasomotor System; Weight Gain	1998
Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects. Contraception, 1999, Volume: 60, Issue:2 Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Egypt; Estradiol; Female; Humans; Injections, Intravenous; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Weight Gain	1999
Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lu Contraception, 1999, Volume: 60, Issue:4 Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Metrorrhagia; Norethindrone; Patient Compliance; Pregnancy; Weight Gain	1999
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability. Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:1 Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain	2002
Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents. Journal of pediatric and adolescent gynecology, 2002, Volume: 15, Issue:3 Topics: Adolescent; Ascorbic Acid; Body Mass Index; Contraceptive Agents, Female; Dietary Supplements; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Satisfaction; Treatment Outcome; Vitamin B 6; Weight Gain	2002
Comparison of diazepam with progestin for effectiveness in suppression of urine spraying behavior in cats. Journal of the American Veterinary Medical Association, 1992, Mar-15, Volume: 200, Issue:6 Topics: Animals; Appetite; Ataxia; Behavior, Animal; Cat Diseases; Cats; Diazepam; Female; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progestins; Recurrence; Sleep; Urination Disorders; Weight Gain	1992

Other Studies

41 other study(ies) available for medroxyprogesterone acetate and Weight Gain

Article	Year
Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia. BMC research notes, 2019, Aug-15, Volume: 12, Issue:1 Topics: Adult; Blood Pressure; Body Mass Index; Body Weight; Bone Density; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Injections; Medroxyprogesterone Acetate; Menstruation; Weight Gain; Young Adult	2019
Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2020, Volume: 25, Issue:1 Topics: Adolescent; Adult; Age Factors; Amenorrhea; Body Mass Index; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Obesity; Retrospective Studies; Time Factors; Weight Gain; Young Adult	2020
Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception, 2013, Volume: 88, Issue:4 Topics: Adolescent; Adult; Black or African American; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Missouri; Progestins; Prospective Studies; Urban Health; Weight Gain; Young Adult	2013
Body weight and body composition of depot medroxyprogesterone acetate users. Contraception, 2014, Volume: 90, Issue:2 Topics: Abdominal Fat; Adiposity; Adolescent; Adult; Brazil; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Matched-Pair Analysis; Medroxyprogesterone Acetate; Middle Aged; Motor Activity; Patient Dropouts; Prospective Studies; Weight Gain; Young Adult	2014
Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2014, Volume: 19, Issue:6 Topics: Adolescent; Adult; Body Composition; Body Mass Index; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Weight Gain; Young Adult	2014
Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2015, Volume: 20, Issue:1 Topics: Adolescent; Adult; Analysis of Variance; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Retrospective Studies; Time Factors; Weight Gain; Young Adult	2015
Dietary Intake and Weight Gain Among Adolescents on Depot Medroxyprogesterone Acetate. Journal of pediatric and adolescent gynecology, 2015, Volume: 28, Issue:3 Topics: Adolescent; Body Mass Index; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Eating; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Prospective Studies; Weight Gain; Young Adult	2015
Serum adipocytokines and adipose weight gain: a pilot study in adolescent females initiating depot medroxyprogesterone acetate. Contraception, 2015, Volume: 92, Issue:4 Topics: Adipokines; Adiposity; Adolescent; Biomarkers; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Pilot Projects; Prospective Studies; Weight Gain; Young Adult	2015
Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2016, Volume: 21, Issue:1 Topics: Adiposity; Adult; Body Composition; Body Mass Index; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Insulin Resistance; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Prospective Studies; Risk Factors; Weight Gain; Young Adult	2016
HelpDesk answers: do hormonal contraceptives lead to weight gain? The Journal of family practice, 2015, Volume: 64, Issue:6 Topics: Adipose Tissue; Body Weight; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Weight Gain	2015
The Effect of Depo Medroxyprogesterone Acetate (DMPA) on Cerebral Food Motivation Centers: A Pilot Study using Functional Magnetic Resonance Imaging. Contraception, 2016, Volume: 94, Issue:4 Topics: Adipose Tissue; Adult; Body Mass Index; Brain; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Food; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Motivation; Oxygen; Photic Stimulation; Pilot Projects; Prospective Studies; Weight Gain; Young Adult	2016
Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills. American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:4 Topics: Acne Vulgaris; Adolescent; Adult; Affect; Bone Density; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Emotions; Female; Hirsutism; Humans; Medroxyprogesterone Acetate; Odds Ratio; Weight Gain	2008
Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstetrics and gynecology, 2009, Volume: 114, Issue:2 Pt 1 Topics: Adolescent; Adult; Appetite; Body Mass Index; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Parity; Pregnancy; Regression Analysis; Weight Gain	2009
Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception. Contraception, 2010, Volume: 81, Issue:1 Topics: Adolescent; Body Mass Index; Body Weight; Contraception Behavior; Contraceptives, Oral, Combined; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Weight Gain; Withholding Treatment; Young Adult	2010
Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive. Contraception, 2010, Volume: 81, Issue:2 Topics: Adult; Analysis of Variance; Body Mass Index; Body Weight; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Medroxyprogesterone Acetate; Obesity; Overweight; Retrospective Studies; Weight Gain	2010
Relationship between weight and bone mineral density in adolescents on hormonal contraception. Journal of pediatric and adolescent gynecology, 2011, Volume: 24, Issue:1 Topics: Adolescent; Body Weight; Bone Density; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Weight Gain	2011
Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate. Obstetrics and gynecology, 2011, Volume: 117, Issue:4 Topics: Adolescent; Analysis of Variance; Anthropometry; Body Mass Index; Body Weight; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Risk Factors; Time Factors; Weight Gain	2011
Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate. American journal of obstetrics and gynecology, 2013, Volume: 208, Issue:1 Topics: Adult; Body Weight; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Medroxyprogesterone Acetate; Self Concept; Weight Gain	2013
Weight and body fat changes in postpartum depot-medroxyprogesterone acetate users. Contraception, 2013, Volume: 88, Issue:1 Topics: Adiposity; Adolescent; Adult; Body Composition; Body Mass Index; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Obesity; Ohio; Overweight; Postnatal Care; Prospective Studies; Reproducibility of Results; Risk; Sterilization, Tubal; Weight Gain; Young Adult	2013
Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). Journal of pediatric and adolescent gynecology, 2004, Volume: 17, Issue:2 Topics: Adolescent; Adult; Black People; Body Composition; Body Mass Index; Contraceptive Agents, Female; Feeding Behavior; Female; Humans; Interviews as Topic; Longitudinal Studies; Medroxyprogesterone Acetate; Obesity; Prospective Studies; Risk Factors; Weight Gain; White People	2004
One step forward, one step back. The good and the bad of office visits. Canadian family physician Medecin de famille canadien, 2004, Volume: 50 Topics: American Indian or Alaska Native; Canada; Family Practice; Female; Humans; Medroxyprogesterone Acetate; Office Visits; Weight Gain	2004
Adolescent use of the monthly contraceptive injection. Journal of pediatric and adolescent gynecology, 2005, Volume: 18, Issue:4 Topics: Adolescent; Adult; Child; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Retrospective Studies; Weight Gain	2005
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria. African journal of reproductive health, 2005, Volume: 9, Issue:2 Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss	2005
Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception, 2007, Volume: 75, Issue:4 Topics: Adult; Age Factors; Body Mass Index; Contraceptive Agents, Female; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Middle Aged; Weight Gain	2007
A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives. Contraception, 1995, Volume: 52, Issue:4 Topics: Adolescent; Adult; Analysis of Variance; Contraceptives, Oral; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Progesterone Congeners; Retrospective Studies; Time Factors; Weight Gain	1995
Beliefs about Depo-Provera among three groups of contraceptors. Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1996, Volume: 12, Issue:1 Topics: Adolescent; Adult; Community Health Services; Contraceptive Agents, Female; Contraceptives, Oral; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Risk Factors; Urban Population; Weight Gain	1996
Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females. Journal of pediatric and adolescent gynecology, 1997, Volume: 10, Issue:1 Topics: Adolescent; Amenorrhea; Black or African American; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Satisfaction; Pregnancy; Prospective Studies; Statistics, Nonparametric; Surveys and Questionnaires; Weight Gain	1997
Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation. Contraception, 1997, Volume: 56, Issue:4 Topics: Adult; Blood Pressure; Contraceptive Agents, Female; Depression; Female; Humans; Medroxyprogesterone Acetate; Menstruation; Middle Aged; New Zealand; Patient Dropouts; Social Class; Surveys and Questionnaires; Weight Gain	1997
Weight variation in users of the once-a-month injectable contraceptive Cyclofem. Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1998, Volume: 14, Issue:4 Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Weight Gain	1998
Role of progestational agents in the treatment of undernourished patients with cystic fibrosis. Pediatric pulmonology, 2000, Volume: 29, Issue:3 Topics: Adolescent; Adult; Appetite Stimulants; Cystic Fibrosis; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Nutrition Disorders; Progesterone Congeners; Weight Gain	2000
Medroxyprogesterone acetate [Depo Provera] injections. Development of striae. The British journal of family planning, 2000, Volume: 26, Issue:2 Topics: Adult; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Progestins; Skin Diseases; Weight Gain	2000
Depomedroxyprogesterone acetate use and weight gain among adolescents. Journal of pediatric and adolescent gynecology, 2000, Volume: 13, Issue:1 Topics: Adolescent; Amenorrhea; Analysis of Variance; Body Mass Index; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Retrospective Studies; Statistics, Nonparametric; Weight Gain	2000
Management of clinical side effects of DMPA. Journal of pediatric and adolescent gynecology, 2000, Volume: 13, Issue:3 Topics: Adolescent; Adolescent Health Services; Alopecia; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Compliance; Patient Satisfaction; Weight Gain	2000
Effect of ovariectomy and hormone replacement therapy on small artery biomechanics in angiotensin-induced hypertension in rats. Journal of hypertension, 2000, Volume: 18, Issue:11 Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Elasticity; Estradiol; Female; Hormone Replacement Therapy; Hypertension; Medroxyprogesterone Acetate; Menopause; Ovariectomy; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Weight Gain	2000
Depo-provera associated with weight gain in Navajo women. Contraception, 2000, Volume: 62, Issue:2 Topics: Adult; Female; Humans; Indians, North American; Medroxyprogesterone Acetate; Parity; Postpartum Period; Retrospective Studies; Weight Gain	2000
Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia. Saudi medical journal, 2000, Volume: 21, Issue:4 Topics: Abdominal Pain; Adult; Alopecia; Back Pain; Contraceptive Agents, Female; Female; Hospitals, Military; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstruation Disturbances; Parity; Patient Acceptance of Health Care; Retrospective Studies; Safety; Saudi Arabia; Surveys and Questionnaires; Time Factors; Weight Gain	2000
Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years. Contraception, 2001, Volume: 64, Issue:4 Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Medroxyprogesterone Acetate; Retrospective Studies; Up-Regulation; Weight Gain	2001
Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice. Nutrition and cancer, 2001, Volume: 39, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Caseins; Diet; Estradiol; Estrogen Receptor alpha; Female; Genistein; Insulin-Like Growth Factor I; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Ovary; Receptors, Estrogen; Skin Neoplasms; Uterus; Weight Gain	2001
Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. Journal of pediatric and adolescent gynecology, 2002, Volume: 15, Issue:2 Topics: Adolescent; Body Mass Index; Contraceptive Agents, Female; Female; Humans; Medical Records; Medroxyprogesterone Acetate; Obesity; Progesterone Congeners; Retrospective Studies; Risk Factors; Weight Gain	2002
Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. British journal of cancer, 1989, Volume: 59, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Aging; Animals; Drug Administration Schedule; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Weight Gain	1989
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Remission Induction; Soft Tissue Neoplasms; Tamoxifen; Weight Gain	1989